date/time interval
- March 1, 2021 - February 29, 2024
A pragmatic randomized controlled trial of a CKD specific telemonitoring platform to minimize adverse outcomes in high risk CKD patients.
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 562275